Results 1 to 10 of about 17,208,238 (361)
Sequence-based drug design as a concept in computational drug design
Drug development based on target proteins has been a successful approach in recent decades. However, the conventional structure-based drug design (SBDD) pipeline is a complex, human-engineered process with multiple independently optimized steps. Here, we
Lifan Chen +23 more
doaj +2 more sources
Drug Design and Delivery for Intracellular Bacteria: Emerging Paradigms. [PDF]
Olowu BI +5 more
europepmc +3 more sources
Structure-based drug design with equivariant diffusion models [PDF]
Structure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets.
Arne Schneuing +11 more
semanticscholar +1 more source
Drug design on quantum computers [PDF]
The promised industrial applications of quantum computers often rest on their anticipated ability to perform accurate, efficient quantum chemical calculations.
R. Santagati +14 more
semanticscholar +1 more source
Structure-based drug design with geometric deep learning [PDF]
Structure-based drug design uses three-dimensional geometric information of macromolecules, such as proteins or nucleic acids, to identify suitable ligands.
Clemens Isert, Kenneth Atz, G. Schneider
semanticscholar +1 more source
Chinese medicine extracts are complex in composition. The combination of the quantitative analysis of multicomponents by single marker (QAMS) and the systematic quantified fingerprint method (SQFM) can be used for better quantitative analysis.
Long Chen +4 more
doaj +1 more source
Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis
In the dynamic landscape of drug discovery, Computer-Aided Drug Design (CADD) emerges as a transformative force, bridging the realms of biology and technology.
Sarfaraz K. Niazi, Zamara Mariam
semanticscholar +1 more source
Structure-based de novo drug design using 3D deep generative models [PDF]
Deep generative models are attracting much attention in the field of de novo molecule design. Compared to traditional methods, deep generative models can be trained in a fully data-driven way with little requirement for expert knowledge.
Yibo Li, Jianfeng Pei, L. Lai
semanticscholar +1 more source
A Guide to In Silico Drug Design
The drug discovery process is a rocky path that is full of challenges, with the result that very few candidates progress from hit compound to a commercially available product, often due to factors, such as poor binding affinity, off-target effects, or ...
Yiqun Chang +5 more
semanticscholar +1 more source
Motivation Application of chemical named entity recognition (CNER) algorithms allows retrieval of information from texts about chemical compound identifiers and creates associations with physical–chemical properties and biological activities.
O. A. Tarasova +4 more
doaj +1 more source

